chitosan has been researched along with Alveolar Echinococcosis, Hepatic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bawudong, D; Chen, YL; Gu, JP; Liu, Y; Ren, WX; Wang, XQ; Xu, XD; Yu, Y; Zhang, JK; Zhang, XN | 1 |
Abulaihaiti, M; Aduwayi, N; Lv, HL; Peng, XY; Qiao, L; Wang, XC; Wang, YJ; Wu, XW; Zhang, HW | 1 |
2 other study(ies) available for chitosan and Alveolar Echinococcosis, Hepatic
Article | Year |
---|---|
Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Biocompatible Materials; Biological Availability; Chitosan; Drug Delivery Systems; Echinococcosis, Hepatic; Female; Intestinal Absorption; Liver; Male; Materials Testing; Mice; Mice, Nude; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley | 2013 |
Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Chitosan; Disease Models, Animal; Drug Carriers; Echinococcosis; Echinococcosis, Hepatic; Echinococcus multilocularis; Histocytochemistry; Liver; Male; Mice; Microspheres; Plasma; Treatment Outcome | 2015 |